Russell Investments »

Rapport Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $69k 2.3k 30.34
2025-09-30 $43k 1.5k 29.70

More positions owned by Russell Investments

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Meta Platforms Common Stock (META)
Broadcom Common Stock (AVGO)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Tesla Common Stock (TSLA)
Eli Lilly And Company Common Stock (LLY)
J P Morgan Chase And Common Stock (JPM)
Visa Common Stock (V)
Johnson Johnson Common Stock (JNJ)

View all positions for Russell Investments

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics